查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1743914

戒菸輔助市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、最終用戶、地區和競爭細分，2020-2030 年）

Smoking Cessation Aids Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End-User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球戒菸輔助市場價值為 230.2 億美元，預計到 2030 年將以 7.28% 的複合年成長率強勁成長。該市場是醫療保健領域的重要組成部分，專注於透過一系列產品和服務幫助個人戒菸。隨著人們對菸草使用相關健康風險的認知不斷提高，戒菸輔助工具的採用率不斷上升。市場包括尼古丁替代療法 (NRT)、處方藥、電子煙和數位介入。德國首款仿製尼古丁口香糖等創新解決方案的推出，以及 Achieve Life Sciences 的 ORCA-V1 研究等試驗的良好臨床結果，凸顯了人們對可及有效戒菸輔助工具的日益重視。技術進步和消費者健康意識的增強正在推動個人化治療方案的開發和應用，為未來幾年市場穩步擴張奠定基礎。

市場概覽
預測期 2026-2030
2024年市場規模 230.2億美元
2030年市場規模 348.1億美元
2025-2030 年複合年成長率 7.28%
成長最快的領域 線上通路
最大的市場 北美洲

關鍵市場促進因素

意識和健康問題日益增強

主要市場挑戰

感知有效性和安全問題

主要市場趨勢

數位戒菸解決方案的興起

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球戒菸輔助市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（尼古丁替代療法、藥物、電子香菸等）
    • 按最終用戶（醫院藥局、線上通路、零售藥局、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美戒菸輔助市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲戒菸輔助市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太地區戒菸輔助產品市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲戒菸輔助市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲戒菸輔助市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球戒菸輔助市場：SWOT 分析

第 14 章：競爭格局

  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Novartis AG
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd
  • Takeda Pharmaceuticals Co. Ltd
  • British American Tobacco PLC
  • Kimree Technology Inc
  • Imperial Tobacco Ltd

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16215

The Global Smoking Cessation Aids Market was valued at USD 23.02 billion in 2024 and is projected to witness robust growth at a CAGR of 7.28% through 2030. This market is a vital part of the healthcare landscape, focused on helping individuals quit smoking through a range of products and services. As awareness of the health risks associated with tobacco use increases, there is rising adoption of smoking cessation aids. The market includes nicotine replacement therapies (NRT), prescription medications, electronic cigarettes, and digital interventions. The introduction of innovative solutions, such as Germany's first generic nicotine chewing gum and promising clinical results from trials like Achieve Life Sciences' ORCA-V1 study, underscores the growing emphasis on accessible and effective quit-smoking aids. Technological advances and growing consumer health consciousness are driving the development and uptake of personalized treatment options, positioning the market for steady expansion in the coming years.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 23.02 Billion
Market Size 2030USD 34.81 Billion
CAGR 2025-20307.28%
Fastest Growing SegmentOnline Channels
Largest MarketNorth America

Key Market Drivers

Rising Awareness and Health Concerns

Increasing awareness of the health hazards linked to tobacco use is a major factor propelling the global smoking cessation aids market. Public understanding of the correlation between smoking and life-threatening diseases-such as cardiovascular disorders, respiratory illnesses, and cancers-has significantly grown, motivating individuals to seek out cessation support. Furthermore, the global emphasis on personal health and well-being is encouraging more people to take proactive steps toward quitting. As individuals prioritize longevity and a higher quality of life, demand for effective, science-backed smoking cessation products continues to rise. This heightened health consciousness is translating into increased usage of both over-the-counter and prescribed quit-smoking aids.

Key Market Challenges

Perceived Effectiveness and Safety Concerns

A notable challenge in the smoking cessation aids market is public skepticism surrounding the effectiveness and safety of available products. Some consumers doubt whether these aids genuinely improve quit rates or worry about potential side effects, particularly with pharmaceutical interventions. This hesitation can discourage individuals from using cessation aids altogether, opting instead for unsupported or self-guided attempts to quit. Addressing these concerns by reinforcing evidence-based outcomes and educating users on proper usage is critical for increasing adoption and trust in cessation therapies.

Key Market Trends

Rise in Digital Smoking Cessation Solutions

A growing trend in the smoking cessation landscape is the adoption of digital tools and services. Mobile apps, online coaching platforms, and telehealth services are becoming increasingly popular for their convenience, accessibility, and personalized features. These platforms offer real-time support, behavioral tracking, and adaptive quit plans that cater to individual needs. The integration of digital solutions reflects the broader shift in healthcare toward technology-driven interventions, opening new opportunities for engagement and treatment effectiveness in the smoking cessation market.

Key Market Players

  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Novartis AG
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd
  • Takeda Pharmaceuticals Co. Ltd
  • British American Tobacco PLC
  • Kimree Technology Inc
  • Imperial Tobacco Ltd

Report Scope:

In this report, the Global Smoking Cessation Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Smoking Cessation Aids Market, By Product:

  • Nicotine Replacement Therapy
  • Drugs
  • Electronic Cigarettes
  • Others

Smoking Cessation Aids Market, By End-User:

  • Hospital Pharmacies
  • Online Channels
  • Retail Pharmacies
  • Other

Smoking Cessation Aids Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Smoking Cessation Aids Market.

Available Customizations:

Global Smoking Cessation Aids market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Smoking Cessation Aids Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, Others)
    • 5.2.2. By End-User (Hospital Pharmacies, Online Channels, Retail Pharmacies, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Smoking Cessation Aids Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Smoking Cessation Aids Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Smoking Cessation Aids Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Smoking Cessation Aids Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-User

7. Europe Smoking Cessation Aids Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Smoking Cessation Aids Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-User
    • 7.3.2. United Kingdom Smoking Cessation Aids Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-User
    • 7.3.3. Italy Smoking Cessation Aids Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-User
    • 7.3.4. France Smoking Cessation Aids Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Smoking Cessation Aids Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End-User

8. Asia-Pacific Smoking Cessation Aids Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Smoking Cessation Aids Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Smoking Cessation Aids Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Smoking Cessation Aids Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Smoking Cessation Aids Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Smoking Cessation Aids Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End-User

9. South America Smoking Cessation Aids Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Smoking Cessation Aids Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-User
    • 9.3.2. Argentina Smoking Cessation Aids Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-User
    • 9.3.3. Colombia Smoking Cessation Aids Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-User

10. Middle East and Africa Smoking Cessation Aids Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Smoking Cessation Aids Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End-User
    • 10.3.2. Saudi Arabia Smoking Cessation Aids Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End-User
    • 10.3.3. UAE Smoking Cessation Aids Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Smoking Cessation Aids Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc.
    • 14.1.1. Business Overview
    • 14.1.2. End-User Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. GlaxoSmithKline PLC
  • 14.3. Hoffmann-La Roche AG
  • 14.4. Novartis AG
  • 14.5. Johnson and Johnson
  • 14.6. Bayer AG
  • 14.7. Cipla Ltd
  • 14.8. Takeda Pharmaceuticals Co. Ltd
  • 14.9. British American Tobacco PLC
  • 14.10. Kimree Technology Inc
  • 14.11. Imperial Tobacco Ltd

15. Strategic Recommendations

16. About Us & Disclaimer